- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00113633
Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma
A Three-part Intervention to Improve Regular Care for Asthma After a Pediatric Emergency Department Visit: A Randomized Clinical Trial
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Inner-city children are particularly at risk for poor asthma treatment outcomes and frequently obtain their asthma care in the ED. Prior studies have had limited success in improving primary care follow-up, quality of care, and long-term outcomes after a pediatric ED visit for asthma. Prior ED-based interventions have been designed to address barriers to follow-up with a primary care provider (PCP) such as an inability to obtain a follow-up appointment or lack of transportation. Focus groups and surveys of inner-city families have found that beliefs about the benefits of follow-up care and the role of preventive asthma medications have a strong impact on adherence to therapy.
This study will develop a brief educational video about the benefits of follow-up asthma care using a multi-disciplinary panel of experts at the Children's Hospital of Philadelphia and focus groups of parents of children with asthma. This educational video will then be combined into an intervention along with symptom screening and a reminder phone call that has been demonstrated to improve follow-up rates in a previous study. The combined intervention will be tested using a randomized trial design to determine its efficacy on healthcare utilization, asthma controller medication use, symptoms, and quality of life during the 6 months following an ED visit. The research is conducted as part of a research career development award.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Children's Hospital of Philadelphia
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 1-18 years
- History of Asthma:
- At least 2 prior episodes of bronchodilator treatment
- No underlying cardiac disease
- No other chronic lung disease
- Residence within Philadelphia city limits
- Discharged from ED after treatment for asthma
Exclusion Criteria:
- Prior study enrollment
- Parent unable to speak English
- No telephone to be reachable for follow-up calls
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Aucune intervention: Control Subjects
These subjects will receive standard discharge instructions that recommend follow-up with a PCP within 3-5 days.
|
|
Expérimental: Intervention Subjects
As part of the intervention, the family will view a brief educational video about asthma control and therapy developed using provider and patient focus groups.
For children reporting persistent asthma symptoms, a letter will be given to the family to bring to their PCP stating that screening revealed symptoms that may require further treatment with controller medications.
A mailed reminder to schedule a follow-up appointment will be sent to the family.
|
The subject's family will view a brief educational video about asthma control and therapy developed using provider and patient focus groups; a mailed reminder will be sent to the family to schedule a follow-up appointment.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Follow-up with a Primary Care Physician (PCP)
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete the Parental Impressions of the Benefits (pros) and barriers (cons) of Follow-Up Care Scale (24-item instrument designed to measure perceived benefits and barriers to follow-up after an ED visit).
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of asthma-related follow-up visits which have been made to the Primary Care Physician.
Information provided by families will be verified by medical record review.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Return to the Emergency Department for an asthma-related visit.
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit.
|
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of asthma-related visits which have been made to the Emergency Department.
Information provided by families will be verified by medical record review.
|
4 weeks, 3 months and 6 months after Emergency Department visit.
|
Persistent asthma symptoms
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening instrument to assess the symptoms of persistent asthma (including cough, wheeze, shortness of breath).
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about asthma symptoms and information will be compared to baseline.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Asthma Controller prescriptions by Primary Care Physician (PCP)
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening interview which will assess asthma history, site of primary care physician and current therapies.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of asthma controller medication prescriptions made by their Primary Care Physician.
Information provided by families will be verified by medical record review.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Asthma controller medication use
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening interview which will assess asthma history, site of primary care physician and current therapies.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about current asthma controller controller medication use.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Days of school/work missed
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening interview which will assess asthma history.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of missed work/school days due to asthma-related reasons.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Peak expiratory flow
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects over the age of 6 will receive a peak expiratory flow meter and instruction as per standard care in the Emergency Department.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about peak expiratory flow meter testing since the initial Emergency Department visit.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Quality of life
Délai: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, parents will be asked to complete the Integrated Therapeutics Group Child Asthma Short Form (8-item asthma-related quality of life questionnaire).
Follow-up telephone contact will be made by the Primary Investigator or a research assistant.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the asthma-related quality of life since the initial Emergency Department visit.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Joseph J. Zorc, Children's Hospital of Philadelphia
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2004-12-4130
- K23HL074250 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Intervention Subjects
-
Biolux Research Holdings, Inc.RésiliéMouvement dentaire orthodontiqueCanada
-
University of FloridaComplété
-
Duke UniversityAgency for Healthcare Research and Quality (AHRQ)ComplétéActivité physique | Habitudes alimentaires | Cesser de fumerÉtats-Unis
-
Sidney Kimmel Cancer Center at Thomas Jefferson...American Cancer Society, Inc.Complété
-
Nottingham Trent UniversityInconnueSurpoids et obésitéRoyaume-Uni
-
Charles University, Czech RepublicUniversity Hospital Ostrava; University Hospital Olomouc; University Hospital... et autres collaborateursRecrutementCancer des ovaires | Fragilité | Cancer de l'endomètre | Cancer de l'ovaire stade IV | Cancer de l'ovaire stade IIITchéquie
-
Istanbul Medipol University HospitalActif, ne recrute pasLombalgie, Posturale | OrthèseTurquie
-
Texas State UniversityKansas State University; Penn State UniversityInconnueCompétences en relations amoureuses | Compétences coparentales
-
Vanderbilt UniversityInscription sur invitationTrouble d'apprentissage des mathématiques | Trouble d'apprentissage de la lectureÉtats-Unis
-
Centre for Addiction and Mental HealthUniversity of Calgary; Lawson Health Research Institute; Douglas Mental Health...Actif, ne recrute pasAgression | La maladie d'Alzheimer | Démence d'Alzheimer (MA)Canada